Cadmus Rich

Track

Insider profile

Currently holds a position at Aura Biosciences Inc

Positions

Position Company Period
Chief Medical Officer Aura Biosciences Inc None -
Cadmus Rich's trades of Aura Biosciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
194.56
Quantity 40,702
Value US$4,965,675
Transaction date
Proposed sale
Price
307.19
Quantity 3,428
Value US$2,662,879
Transaction date
Proposed sale
Price
8.85
Quantity 90,039
Value US$796,845
Transaction date
Proposed sale
Price
6.81
Quantity 1,706
Value US$11,620
Transaction date
Planned sale
Price
12.45
Quantity 1,672 -6.4%
Value US$20,813
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-04 2024-03-04
PrS Proposed sale
36,805
494.31
US$183,224 		36,805 494.31 US$183,224
2024-02-23 2024-02-23
PrS Proposed sale
40,702
194.56
US$4,965,675 		40,702 194.56 US$4,965,675
2024-01-08 2024-01-08
PrS Proposed sale
3,428
307.19
US$2,662,879 		3,428 307.19 US$2,662,879
2024-01-02 2024-01-02
PrS Proposed sale
9,748
8.86
US$86,367 		9,748 8.86 US$86,367
2023-12-15 2023-12-15
PrS Proposed sale
90,039
8.85
US$796,845 		90,039 8.85 US$796,845
2023-11-03 2023-10-30
PrS Proposed sale
1,706
6.81
US$11,620 		1,706 6.81 US$11,620
2022-11-02 2022-10-31
PlS Planned sale
1,672 -6.4%
12.45
US$20,813 		1,672 -6.4% 12.45 US$20,813